Free Trial

Agios Pharmaceuticals (AGIO) Competitors

Agios Pharmaceuticals logo
$30.94 +1.25 (+4.21%)
Closing price 05/1/2025 04:00 PM Eastern
Extended Trading
$30.94 -0.01 (-0.02%)
As of 04:02 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

AGIO vs. LEGN, TGTX, TLX, BPMC, SRPT, AXSM, NUVL, VRNA, GRFS, and KRYS

Should you be buying Agios Pharmaceuticals stock or one of its competitors? The main competitors of Agios Pharmaceuticals include Legend Biotech (LEGN), TG Therapeutics (TGTX), Telix Pharmaceuticals Limited American Depositary Shares (TLX), Blueprint Medicines (BPMC), Sarepta Therapeutics (SRPT), Axsome Therapeutics (AXSM), Nuvalent (NUVL), Verona Pharma (VRNA), Grifols (GRFS), and Krystal Biotech (KRYS). These companies are all part of the "pharmaceutical products" industry.

Agios Pharmaceuticals vs.

Legend Biotech (NASDAQ:LEGN) and Agios Pharmaceuticals (NASDAQ:AGIO) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, dividends, earnings, community ranking, media sentiment, valuation, risk, analyst recommendations and institutional ownership.

Legend Biotech has a beta of 0.21, suggesting that its stock price is 79% less volatile than the S&P 500. Comparatively, Agios Pharmaceuticals has a beta of 0.83, suggesting that its stock price is 17% less volatile than the S&P 500.

Agios Pharmaceuticals has a net margin of 1,845.92% compared to Legend Biotech's net margin of -66.92%. Agios Pharmaceuticals' return on equity of -2.51% beat Legend Biotech's return on equity.

Company Net Margins Return on Equity Return on Assets
Legend Biotech-66.92% -29.69% -19.45%
Agios Pharmaceuticals 1,845.92%-2.51%-2.26%

Agios Pharmaceuticals received 401 more outperform votes than Legend Biotech when rated by MarketBeat users. However, 72.58% of users gave Legend Biotech an outperform vote while only 66.98% of users gave Agios Pharmaceuticals an outperform vote.

CompanyUnderperformOutperform
Legend BiotechOutperform Votes
90
72.58%
Underperform Votes
34
27.42%
Agios PharmaceuticalsOutperform Votes
491
66.98%
Underperform Votes
242
33.02%

Legend Biotech currently has a consensus price target of $78.82, indicating a potential upside of 132.09%. Agios Pharmaceuticals has a consensus price target of $56.57, indicating a potential upside of 82.84%. Given Legend Biotech's stronger consensus rating and higher probable upside, analysts clearly believe Legend Biotech is more favorable than Agios Pharmaceuticals.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Legend Biotech
0 Sell rating(s)
1 Hold rating(s)
11 Buy rating(s)
0 Strong Buy rating(s)
2.92
Agios Pharmaceuticals
0 Sell rating(s)
4 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.56

In the previous week, Agios Pharmaceuticals had 6 more articles in the media than Legend Biotech. MarketBeat recorded 13 mentions for Agios Pharmaceuticals and 7 mentions for Legend Biotech. Legend Biotech's average media sentiment score of 1.25 beat Agios Pharmaceuticals' score of 0.93 indicating that Legend Biotech is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Legend Biotech
5 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Agios Pharmaceuticals
6 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Agios Pharmaceuticals has lower revenue, but higher earnings than Legend Biotech. Legend Biotech is trading at a lower price-to-earnings ratio than Agios Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Legend Biotech$627.24M9.94-$518.25M-$0.48-70.75
Agios Pharmaceuticals$36.50M49.10$673.72M$11.342.73

70.9% of Legend Biotech shares are owned by institutional investors. 0.0% of Legend Biotech shares are owned by insiders. Comparatively, 4.9% of Agios Pharmaceuticals shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

Agios Pharmaceuticals beats Legend Biotech on 11 of the 18 factors compared between the two stocks.

Get Agios Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for AGIO and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AGIO vs. The Competition

MetricAgios PharmaceuticalsPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$1.72B$6.84B$5.53B$7.93B
Dividend YieldN/A3.05%5.11%4.22%
P/E Ratio2.737.3222.5118.54
Price / Sales49.10241.49397.62103.30
Price / CashN/A65.8538.1834.62
Price / Book1.156.486.734.25
Net Income$673.72M$143.41M$3.22B$248.18M
7 Day Performance5.74%2.30%1.58%1.25%
1 Month Performance12.92%7.14%4.05%3.76%
1 Year Performance-8.08%-2.61%15.75%5.28%

Agios Pharmaceuticals Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AGIO
Agios Pharmaceuticals
4.2301 of 5 stars
$30.94
+4.2%
$56.57
+82.8%
-8.1%$1.72B$36.50M2.73390Earnings Report
Analyst Upgrade
Analyst Revision
LEGN
Legend Biotech
2.6365 of 5 stars
$32.24
-1.7%
$79.00
+145.0%
-22.8%$5.92B$627.24M-33.941,070
TGTX
TG Therapeutics
3.3045 of 5 stars
$36.97
-3.5%
$40.67
+10.0%
+185.7%$5.81B$329.00M-369.66290Upcoming Earnings
Positive News
TLX
Telix Pharmaceuticals Limited American Depositary Shares
N/A$16.21
-3.0%
$22.00
+35.7%
N/A$5.48B$783.21M0.00N/AAnalyst Revision
News Coverage
Gap Down
BPMC
Blueprint Medicines
2.5578 of 5 stars
$84.18
-0.6%
$124.95
+48.4%
+4.6%$5.38B$508.82M-77.94640Earnings Report
Analyst Forecast
Positive News
SRPT
Sarepta Therapeutics
4.7419 of 5 stars
$55.23
+2.7%
$158.70
+187.3%
-52.0%$5.36B$1.90B44.18840Upcoming Earnings
AXSM
Axsome Therapeutics
4.8333 of 5 stars
$103.00
-1.4%
$169.80
+64.9%
+49.9%$5.02B$385.69M-17.20380Upcoming Earnings
Analyst Forecast
Short Interest ↓
Positive News
NUVL
Nuvalent
1.8833 of 5 stars
$69.95
-2.4%
$115.50
+65.1%
+7.9%$5.01BN/A-20.1640Upcoming Earnings
Positive News
VRNA
Verona Pharma
2.9044 of 5 stars
$60.07
+2.0%
$75.43
+25.6%
+374.8%$4.85B$42.28M-31.2930Earnings Report
Analyst Forecast
Insider Trade
Short Interest ↓
Analyst Revision
News Coverage
Positive News
GRFS
Grifols
3.8942 of 5 stars
$7.01
-1.0%
N/A+3.4%$4.82B$7.21B5.9926,300Short Interest ↓
Positive News
KRYS
Krystal Biotech
4.905 of 5 stars
$161.91
-4.0%
$220.00
+35.9%
+3.8%$4.68B$290.52M54.15210Upcoming Earnings
Analyst Revision
Positive News

Related Companies and Tools


This page (NASDAQ:AGIO) was last updated on 5/2/2025 by MarketBeat.com Staff
From Our Partners